SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLXN - has aquired the worldwide exclusive rights ThyroTest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
From: Greenvision10/6/2008 7:31:20 PM
   of 6
 
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

CLXN acquired the worldwide Exclusiv rights ThyroTest pharmaceuticals & secured $$$$

1 .) CLXN acquired the worldwide Exclusivr rightsThyroTest pharmaceuticals & secured patents, the secret full, the Pharmaceutica existed all tests and released the releases of supervision authority for Medikamnet for the sale, sale for the first time into USA and Europe, after that marketing and sale in all remaining countries $$$$

2.) a Merger, sprich a fusion stands and/or becomes me expected with one of the large pharmaceutical groups in the USA gigantic, a true pearl, whom, is supposed to be announced on Wednesday after stock exchange end

Who can buy in the USA, would think needs one not long consider

100 excavators and more.

First Target Price: 0.10 US$, momentary cure: 0,0005 US$ = that 200 of specialties = 200Bagger

This Wednesday, after stock exchange end News are expected with the publication above mentioned. News so that it will make this Thursday yet KAABOOOOOOOOOM.

ALL IMO & GLTA

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext